CASI Pharmaceuticals Inc. (CASI) NASDAQ
$2.24 (0.10) (-4.27%)
Market Cap: $31.36M
As of 04/17/24 04:00 PM EDT. Market closed.
CASI Pharmaceuticals Inc. (CASI)
NASDAQ
$2.24
(0.10) (-4.27%)
Market Cap: $31.36M
As of 04/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The ... read more
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO Compensation (Base)
$427,980
CEO Compensation (Total)
$1.24M
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Wei-Wu He
CEO Compensation (Base)
$427,980
CEO Compensation (Total)
$1.24M
Address
9620 Medical Center Dr Ste 300, Maryland, Rockville, 20850-3396.
PRICE CHART FOR CASI PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.21
Previous Close
$2.34
Days Range
$2.10 - $2.47
52 week range
$1.85 - $8.48
Volume
41,073
Avg. Volume (30 days)
62,153
Market Cap
$31.36M
Dividend Yield
-
P/E
-
Shares Outstanding
13,401,375
Open
$2.21
Previous Close
$2.34
Days Range
$2.10 - $2.47
52 week range
$1.85 - $8.48
Volume
41,073
Avg. Volume (30 days)
62,153
Market Cap
$31.36M
Dividend Yield
-
P/E
-
Shares Outstanding
13,401,375
FINANCIAL STATEMENTS FOR CASI PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CASI PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Huang James | Director | Sep 06, 2022 | Buy | $3.89 | 19,162 | 74,601 | 335,106 | Sep 08, 2022, 06:51 PM |
| Huang James | Director | Sep 08, 2022 | Buy | $4.28 | 33,300 | 142,627 | 371,517 | Sep 08, 2022, 06:51 PM |
| Huang James | Director | Sep 07, 2022 | Buy | $4.00 | 3,111 | 12,433 | 338,217 | Sep 08, 2022, 06:51 PM |
| Huang James | Director | Sep 02, 2022 | Buy | $3.74 | 400 | 1,497 | 315,944 | Sep 02, 2022, 07:35 PM |
| Huang James | Director | Sep 01, 2022 | Buy | $3.72 | 11,821 | 44,008 | 315,544 | Sep 02, 2022, 07:35 PM |
| Huang James | Director | Aug 31, 2022 | Buy | $3.74 | 24,975 | 93,531 | 303,723 | Sep 02, 2022, 07:35 PM |
| Huang James | Director | Aug 26, 2022 | Buy | $3.75 | 39,527 | 148,179 | 278,748 | Aug 26, 2022, 08:48 PM |
| Huang James | Director | Aug 24, 2022 | Buy | $3.75 | 5,000 | 18,751 | 239,221 | Aug 26, 2022, 08:48 PM |
| Huang James | Director | Aug 22, 2022 | Buy | $3.46 | 23,105 | 80,038 | 194,221 | Aug 23, 2022, 08:19 PM |
| Huang James | Director | Aug 19, 2022 | Buy | $3.27 | 171,116 | 559,447 | 171,116 | Aug 23, 2022, 08:19 PM |
| Huang James | Director | Aug 23, 2022 | Buy | $3.50 | 40,000 | 139,992 | 234,221 | Aug 23, 2022, 08:19 PM |
| He Wei-Wu | Chairman and CEO | Jun 13, 2022 | Buy | $2.97 | 36,058 | 107,092 | 592,457 | Jun 17, 2022, 04:14 PM |
| He Wei-Wu | Chairman and CEO | Jun 15, 2022 | Buy | $3.18 | 50,000 | 159,000 | 644,553 | Jun 17, 2022, 04:14 PM |
| He Wei-Wu | Chairman and CEO | Jun 14, 2022 | Buy | $3.06 | 2,096 | 6,414 | 594,553 | Jun 17, 2022, 04:14 PM |
| He Wei-Wu | Chairman and CEO | Nov 18, 2021 | Buy | $0.98 | 200,000 | 196,000 | 5,558,472 | Nov 19, 2021, 04:10 PM |
| He Wei-Wu | Chairman and CEO | Nov 17, 2021 | Buy | $0.99 | 200,000 | 198,000 | 5,362,569 | Nov 19, 2021, 04:10 PM |
| He Wei-Wu | Chairman and CEO | Aug 19, 2021 | Buy | $1.26 | 180,000 | 226,800 | 5,163,994 | Aug 20, 2021, 04:27 PM |
| He Wei-Wu | Chairman and CEO | Aug 18, 2021 | Buy | $1.29 | 300,000 | 387,000 | 4,983,994 | Aug 20, 2021, 04:27 PM |
| He Wei-Wu | Chairman and CEO | Mar 26, 2021 | Buy | $2.05 | 3,000,000 | 6,150,000 | 3,000,000 | Mar 30, 2021, 04:52 PM |
| Xu Weihao | Chief Financial Officer | Dec 17, 2020 | Buy | $2.63 | 4,000 | 10,537 | 10,000 | Dec 18, 2020, 04:05 PM |
| Xu Weihao | Chief Financial Officer | Dec 16, 2020 | Buy | $2.44 | 2,000 | 4,880 | 6,000 | Dec 18, 2020, 04:05 PM |
| He Wei-Wu | Chairman and CEO | Nov 23, 2020 | Buy | $2.18 | 100,000 | 218,000 | 5,063,994 | Nov 24, 2020, 05:39 PM |
| He Wei-Wu | Chairman and CEO | Nov 20, 2020 | Buy | $2.12 | 127,471 | 270,239 | 4,963,994 | Nov 24, 2020, 05:39 PM |
| Zhang Larry | President | Jul 22, 2020 | Buy | $1.90 | 20,153 | 38,291 | 20,153 | Jul 24, 2020, 04:05 PM |
| He Wei-Wu | Chairman and CEO | Jul 22, 2020 | Buy | $1.90 | 2,952,426 | 5,609,609 | 4,836,523 | Jul 24, 2020, 04:03 PM |
| He Wei-Wu | Chairman and CEO | Jul 22, 2020 | Buy | $1.90 | 1,200,000 | 2,280,000 | 7,532,347 | Jul 24, 2020, 04:03 PM |
| He Wei-Wu | Chairman and CEO | May 20, 2020 | Buy | $2.37 | 56,464 | 133,820 | 1,884,097 | May 21, 2020, 05:01 PM |
| He Wei-Wu | Chairman and CEO | May 19, 2020 | Buy | $2.03 | 29,801 | 60,496 | 1,827,663 | May 21, 2020, 05:01 PM |
| He Wei-Wu | Chairman and CEO | May 18, 2020 | Buy | $2.02 | 338,932 | 684,643 | 1,797,832 | May 19, 2020, 05:55 PM |
| He Wei-Wu | Chairman and CEO | May 15, 2020 | Buy | $1.82 | 100,000 | 182,000 | 1,458,900 | May 19, 2020, 05:55 PM |
| He Wei-Wu | Chairman and CEO | Mar 27, 2020 | Buy | $2.08 | 6,880 | 14,310 | 1,358,900 | Mar 30, 2020, 04:01 PM |
| He Wei-Wu | Chairman and CEO | Mar 26, 2020 | Buy | $2.09 | 328,095 | 685,719 | 1,352,020 | Mar 27, 2020, 05:07 PM |
| He Wei-Wu | Chairman and CEO | Mar 25, 2020 | Buy | $1.94 | 196,398 | 381,012 | 1,023,925 | Mar 27, 2020, 05:07 PM |
| He Wei-Wu | Chairman and CEO | Mar 19, 2020 | Buy | $1.57 | 234,488 | 368,146 | 6,332,347 | Mar 19, 2020, 05:39 PM |
| He Wei-Wu | Chairman and CEO | Mar 18, 2020 | Buy | $1.52 | 501,322 | 762,009 | 6,097,859 | Mar 19, 2020, 05:39 PM |
| He Wei-Wu | Chairman and CEO | Mar 17, 2020 | Buy | $1.50 | 264,192 | 396,288 | 5,596,537 | Mar 19, 2020, 05:39 PM |
| Wealth Strategy Holding Ltd | 10% Owner | Dec 30, 2019 | Option Exercise | $1.69 | 493,827 | 834,568 | 9,087,888 | Jan 06, 2020, 12:00 AM |
| He Wei-Wu | Chairman and CEO | Dec 16, 2019 | Option Exercise | $1.69 | 374,321 | 632,603 | 5,332,345 | Dec 18, 2019, 04:01 PM |
| He Wei-Wu | Chief Executive Officer | Aug 16, 2019 | Buy | $3.20 | 20,000 | 64,000 | 827,527 | Aug 20, 2019, 04:30 PM |
| He Wei-Wu | Chief Executive Officer | Aug 14, 2019 | Buy | $3.17 | 160,000 | 507,200 | 807,527 | Aug 15, 2019, 04:51 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Apr 02, 2019 | Option Exercise | $3.38 | 1,500,000 | 5,074,200 | 5,397,413 | Apr 04, 2019, 07:30 PM |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | Jan 14, 2019 | Option Exercise | $3.79 | 3,100 | 11,749 | 29,685 | Jan 15, 2019, 04:02 PM |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | Jan 14, 2019 | Option Exercise | $1.76 | 15,000 | 26,400 | 32,785 | Jan 15, 2019, 04:02 PM |
| SPARKLE BYTE LTD | 10% Owner | Nov 13, 2018 | Option Exercise | $1.69 | 1,699,753 | 2,872,583 | 10,198,518 | Nov 14, 2018, 06:04 AM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Jul 12, 2018 | Option Exercise | $7.49 | 26,600 | 199,215 | 0 | Jul 13, 2018, 05:09 PM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Jul 12, 2018 | Option Exercise | $7.49 | 8,400 | 62,910 | 26,600 | Jul 13, 2018, 05:09 PM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Jul 12, 2018 | Option Exercise | $1.99 | 35,000 | 69,475 | 35,000 | Jul 13, 2018, 05:09 PM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Apr 12, 2018 | Option Exercise | $6.62 | 18,778 | 124,310 | 0 | Apr 13, 2018, 06:03 PM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Apr 12, 2018 | Option Exercise | $6.62 | 8,200 | 54,284 | 18,778 | Apr 13, 2018, 06:03 PM |
| CAPITELLI SARA B | VP Fin & Principal Account Off | Apr 12, 2018 | Option Exercise | $0.88 | 26,978 | 23,741 | 26,978 | Apr 13, 2018, 06:03 PM |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | Mar 21, 2018 | Buy | $3.19 | 204,320 | 651,781 | 646,995 | Mar 23, 2018, 03:03 PM |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | Mar 21, 2018 | Buy | $3.19 | 2,882,098 | 9,193,893 | 9,126,375 | Mar 23, 2018, 03:03 PM |
| He Wei-Wu | Director | Mar 19, 2018 | Buy | $3.24 | 3,086,419 | 9,999,998 | 4,958,024 | Mar 21, 2018, 06:53 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Dec 22, 2017 | Buy | $0.01 | 611,740 | 6,117 | 4,650,262 | Dec 22, 2017, 03:38 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Dec 22, 2017 | Buy | $0.01 | 907,356 | 9,074 | 6,897,413 | Dec 22, 2017, 03:38 PM |
| He Wei-Wu | Director | Oct 10, 2017 | Buy | $1.95 | 100,000 | 195,000 | 847,527 | Oct 11, 2017, 04:56 PM |
| He Wei-Wu | Director | Oct 05, 2017 | Buy | $1.80 | 100,000 | 180,000 | 647,527 | Oct 10, 2017, 05:01 PM |
| He Wei-Wu | Director | Oct 06, 2017 | Buy | $1.86 | 100,000 | 186,000 | 747,527 | Oct 10, 2017, 05:01 PM |
| He Wei-Wu | Director | Sep 19, 2017 | Buy | $1.78 | 34,002 | 60,524 | 547,527 | Sep 20, 2017, 05:00 PM |
| He Wei-Wu | Director | Sep 18, 2017 | Buy | $1.75 | 173,500 | 303,625 | 513,525 | Sep 20, 2017, 05:00 PM |
| He Wei-Wu | Director | Sep 15, 2017 | Buy | $1.49 | 127,702 | 190,276 | 340,025 | Sep 18, 2017, 06:51 PM |
| He Wei-Wu | Director | Sep 14, 2017 | Buy | $1.22 | 187,625 | 228,903 | 212,323 | Sep 18, 2017, 06:51 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Oct 28, 2016 | Buy | $0.01 | 1,068,605 | 10,686 | 5,990,057 | Nov 01, 2016, 06:51 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Oct 28, 2016 | Buy | $0.01 | 720,457 | 7,205 | 4,038,522 | Nov 01, 2016, 06:51 PM |
| He Wei-Wu | Director | Oct 03, 2016 | Buy | $1.19 | 1,871,605 | 2,227,210 | 1,871,605 | Oct 05, 2016, 04:51 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Jul 20, 2016 | Buy | $0.01 | 66,255 | 663 | 3,318,065 | Aug 16, 2016, 07:16 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Jul 14, 2016 | Buy | $0.01 | 394,942 | 3,949 | 3,251,810 | Aug 16, 2016, 07:16 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Jul 20, 2016 | Buy | $0.01 | 98,271 | 983 | 4,921,452 | Aug 16, 2016, 07:16 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Jul 14, 2016 | Buy | $0.01 | 585,790 | 5,858 | 4,823,181 | Aug 16, 2016, 07:16 PM |
| SPARKLE BYTE LTD | 10% Owner | Jun 24, 2016 | Buy | $1.19 | 3,753,855 | 4,467,088 | 8,498,765 | Jun 29, 2016, 09:58 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Feb 22, 2016 | Buy | $0.01 | 680,113 | 6,801 | 2,856,868 | Mar 11, 2016, 07:43 PM |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | Feb 22, 2016 | Buy | $0.01 | 1,008,764 | 10,088 | 4,237,391 | Mar 11, 2016, 07:43 PM |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | Mar 07, 2013 | Buy | $2.40 | 68,958 | 165,499 | 360,947 | Jan 27, 2016, 09:23 PM |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | Mar 07, 2013 | Buy | $2.40 | 972,708 | 2,334,499 | 5,091,438 | Jan 27, 2016, 09:23 PM |
| Ren Ken Keyong | CEO and Director | Jan 19, 2016 | Buy | $0.73 | 15,000 | 10,894 | 15,000 | Jan 21, 2016, 03:55 PM |
| Ren Ken | CEO and Director | Jan 19, 2016 | Buy | $0.73 | 15,000 | 10,894 | 15,000 | Jan 21, 2016, 02:44 PM |
| Hu Cynthia W. | COO | Jan 19, 2016 | Buy | $0.72 | 16,800 | 12,111 | 17,785 | Jan 21, 2016, 02:43 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Huang James | Director | 09/06/2022 | 74,601 |
| Huang James | Director | 09/08/2022 | 142,627 |
| Huang James | Director | 09/07/2022 | 12,433 |
| Huang James | Director | 09/02/2022 | 1,497 |
| Huang James | Director | 09/01/2022 | 44,008 |
| Huang James | Director | 08/31/2022 | 93,531 |
| Huang James | Director | 08/26/2022 | 148,179 |
| Huang James | Director | 08/24/2022 | 18,751 |
| Huang James | Director | 08/22/2022 | 80,038 |
| Huang James | Director | 08/19/2022 | 559,447 |
| Huang James | Director | 08/23/2022 | 139,992 |
| He Wei-Wu | Chairman and CEO | 06/13/2022 | 107,092 |
| He Wei-Wu | Chairman and CEO | 06/15/2022 | 159,000 |
| He Wei-Wu | Chairman and CEO | 06/14/2022 | 6,414 |
| He Wei-Wu | Chairman and CEO | 11/18/2021 | 196,000 |
| He Wei-Wu | Chairman and CEO | 11/17/2021 | 198,000 |
| He Wei-Wu | Chairman and CEO | 08/19/2021 | 226,800 |
| He Wei-Wu | Chairman and CEO | 08/18/2021 | 387,000 |
| He Wei-Wu | Chairman and CEO | 03/26/2021 | 6,150,000 |
| Xu Weihao | Chief Financial Officer | 12/17/2020 | 10,537 |
| Xu Weihao | Chief Financial Officer | 12/16/2020 | 4,880 |
| He Wei-Wu | Chairman and CEO | 11/23/2020 | 218,000 |
| He Wei-Wu | Chairman and CEO | 11/20/2020 | 270,239 |
| Zhang Larry | President | 07/22/2020 | 38,291 |
| He Wei-Wu | Chairman and CEO | 07/22/2020 | 5,609,609 |
| He Wei-Wu | Chairman and CEO | 07/22/2020 | 2,280,000 |
| He Wei-Wu | Chairman and CEO | 05/20/2020 | 133,820 |
| He Wei-Wu | Chairman and CEO | 05/19/2020 | 60,496 |
| He Wei-Wu | Chairman and CEO | 05/18/2020 | 684,643 |
| He Wei-Wu | Chairman and CEO | 05/15/2020 | 182,000 |
| He Wei-Wu | Chairman and CEO | 03/27/2020 | 14,310 |
| He Wei-Wu | Chairman and CEO | 03/26/2020 | 685,719 |
| He Wei-Wu | Chairman and CEO | 03/25/2020 | 381,012 |
| He Wei-Wu | Chairman and CEO | 03/19/2020 | 368,146 |
| He Wei-Wu | Chairman and CEO | 03/18/2020 | 762,009 |
| He Wei-Wu | Chairman and CEO | 03/17/2020 | 396,288 |
| Wealth Strategy Holding Ltd | 10% Owner | 12/30/2019 | 834,568 |
| He Wei-Wu | Chairman and CEO | 12/16/2019 | 632,603 |
| He Wei-Wu | Chief Executive Officer | 08/16/2019 | 64,000 |
| He Wei-Wu | Chief Executive Officer | 08/14/2019 | 507,200 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 04/02/2019 | 5,074,200 |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | 01/14/2019 | 11,749 |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | 01/14/2019 | 26,400 |
| SPARKLE BYTE LTD | 10% Owner | 11/13/2018 | 2,872,583 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 07/12/2018 | 199,215 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 07/12/2018 | 62,910 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 07/12/2018 | 69,475 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 04/12/2018 | 124,310 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 04/12/2018 | 54,284 |
| CAPITELLI SARA B | VP Fin & Principal Account Off | 04/12/2018 | 23,741 |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | 03/21/2018 | 651,781 |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | 03/21/2018 | 9,193,893 |
| He Wei-Wu | Director | 03/19/2018 | 9,999,998 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 12/22/2017 | 6,117 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 12/22/2017 | 9,074 |
| He Wei-Wu | Director | 10/10/2017 | 195,000 |
| He Wei-Wu | Director | 10/05/2017 | 180,000 |
| He Wei-Wu | Director | 10/06/2017 | 186,000 |
| He Wei-Wu | Director | 09/19/2017 | 60,524 |
| He Wei-Wu | Director | 09/18/2017 | 303,625 |
| He Wei-Wu | Director | 09/15/2017 | 190,276 |
| He Wei-Wu | Director | 09/14/2017 | 228,903 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 10/28/2016 | 10,686 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 10/28/2016 | 7,205 |
| He Wei-Wu | Director | 10/03/2016 | 2,227,210 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 07/20/2016 | 663 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 07/14/2016 | 3,949 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 07/20/2016 | 983 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 07/14/2016 | 5,858 |
| SPARKLE BYTE LTD | 10% Owner | 06/24/2016 | 4,467,088 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 02/22/2016 | 6,801 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 02/22/2016 | 10,088 |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | 03/07/2013 | 165,499 |
| IDG-Accel China Growth Fund III L.P. | 10% Owner | 03/07/2013 | 2,334,499 |
| Ren Ken Keyong | CEO and Director | 01/19/2016 | 10,894 |
| Ren Ken | CEO and Director | 01/19/2016 | 10,894 |
| Hu Cynthia W. | COO | 01/19/2016 | 12,111 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CASI PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 29,100 | 0.00032% | 63.48% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 22,221 | 0.00002% | No change | Other |
| BLACKROCK INC. | 296 | 0% | -8.64% | Other |
CHANGE IN SHARES OUTSTANDING FOR CASI PHARMACEUTICALS INC
STOCK BUYBACKS FOR CASI PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0%
1Q
06/30/2023
0.25%
2Q
03/31/2023
0.29%
3Q
12/31/2022
-1.51%
4Q
09/30/2022
-1.67%
5Q
06/30/2022
-1.67%
6Q
03/31/2022
-3.02%
7Q
12/31/2021
-4.33%
8Q
09/30/2021
-4.30%
9Q
06/30/2021
-4.30%
10Q
03/31/2021
7.18%
11Q
12/31/2020
7.86%
12Q
09/30/2020
13.43%
13Q
06/30/2020
32.56%
14Q
03/31/2020
35.45%
15Q
12/31/2019
38.59%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CASI PHARMACEUTICALS INC
LOADING...